Proliferative Markers of Breast Cancer.
- Author:
Sang Hoon BOK
1
;
Geumhee GWAG
;
Keun Ho YANG
;
Byung Noe BAE
;
Ki Hwan KIM
;
Hong Joo KIM
;
Young Duck KIM
;
Hong Yong KIM
;
Kyeongmee PARK
;
Sehwan HAN
Author Information
- Publication Type:Original Article
- Keywords: Breast cancer; Mitotic index; Ki-67 labeling index; Topoisomerase II alpha
- MeSH: Breast Neoplasms*; Breast*; DNA Topoisomerases, Type II; Lymph Nodes; Mitotic Index
- From:Journal of Breast Cancer 2005;8(4):165-171
- CountryRepublic of Korea
- Language:Korean
- Abstract: PURPOSE: The mitotic index (MI) and Ki-67 labeling index have been used as cell proliferative markers in the various tumors. Topoisomerase II alpha (Topo II alpha) is also expressed in proliferating cells. The aim of this study was to evaluate the correlations between the MI, Ki-67, and Topo II alpha expression as proliferative markers of breast cancer. METHODS: The cell proliferative activity of 181 breast cancers was measured using MI, Ki-67 labeling index and Topo II alpha expression. The correlation between the measured markers was also analyzed. RESULTS: The MI, Ki-67, and Topo II alpha were significantly correlated with each other(p < 0.000). The MI and Ki-67 labeling index were associated with high histological grade, and absence of hormone receptor (p < 0.000). Topo II alpha expression was correlated with high histological grade (p < 0.000), absence of hormone receptor and HER-2/neu overexpression (p < 0.043). The MI, Ki-67, and Topo II alpha were not associated with any other clinical variables, such as age, tumor size, and lymph node status. CONCLUSION: The three proliferative indices were significantly associated with aggressive features of breast cancer, and significantly correlated with each other.
